Register / Log In

Correct diagnosis of thinning hair critical to appropriate treatments




Dr. Price
San Francisco — Thinning hair is often a result of the aging process, and it affects both men and women in their later decades, usually around age 60, according to Vera Price, M.D., F.R.C.P.C., professor of dermatology, University of California, San Francisco.

"It may start in some individuals before that age, in their 50s, and in others, it may be after that, in their 70s or later," Dr. Price says. "Some individuals do not have it."

Patients typically notice less hair on top of their heads when they experience age-related hair thinning, but increased shedding is usually not associated with this, Dr. Price says.

Different causes

Age-related hair thinning is not just a continuation of androgenetic alopecia, according to Dr. Price. Some men and women who have age-related thinning may have developed androgenetic alopecia earlier in life, in their 20s, 30s or 40s, she says.

"Androgenetic alopecia and age-related thinning are due to different mechanisms," Dr. Price says. "Androgenetic alopecia is caused by an enzyme, 5-alpha reductase, that converts the male hormone testosterone to a more potent male hormone, dihydrotestosterone, in genetically-prone men and women."

Age-related thinning is not male hormone-driven; rather, it is part of the aging process, which is not well understood.

"We do know that in our later decades, the amount of the enzyme 5-alpha reductase is greatly decreased in the scalp, and age-related thinning also involves a genetic predilection," she says.

Many dermatologists do not recognize age-related thinning as a distinct entity from androgenetic alopecia. This is because biopsies from the two conditions look similar, Dr. Price says. In both conditions, the follicle becomes smaller and smaller, the oil glands remain large, and there is no scarring. In other words, the two conditions cannot be distinguished under the microscope.

Appropriate therapies

Dr. Price says the reason to differentiate the two conditions is for proper treatment selection. Since age-related hair thinning is not driven by male hormones, "Finasteride will not be effective," Dr. Price says.

Age-related thinning will respond to minoxidil, which currently is the only treatment available for the condition. Younger patients with androgenetic alopecia have the option of using minoxidil, finasteride or both, Dr. Price says.

It is important to be sure that there are no other causes involved other than age when patients present with hair thinning.

"I like to check certain laboratory tests to be sure we are not dealing with any other cause of hair thinning other than age," Dr. Price says. "I check the blood count, thyroid-stimulating hormone, ferritin and vitamin [25(OH)] D."

In addition, a clinician should determine the medications that a patient has been taking, as well as whether a patient has recently experienced an acute illness or a high fever.


Nails undergo a significant number of changes in elderly patients, including discoloration, increased curvature and a 40 percent reduction in the growth rate, according to Richard K. Scher, M.D., professor emeritus, dermatology, Columbia University, New York, and the University of North Carolina, Chapel Hill.

A survey by Merritt Hawkins found that patients wait 22.1 days on average to see a dermatologist, with waits ranging from 3.4 to 104.4 days, depending on the geographical location. Physician assistants and nurse practitioners offer dermatologists an excellent way to expand their availability to more patients, but the value of these advanced practice providers goes well beyond scheduling.

Solar lentigines are common in the aging patient, with 90 percent of Caucasians over age 60 having the condition. Even those who diligently used sunscreen may experience lentigines, because most sunscreens don't block all UV waves.

Preliminary results of a study evaluating biopsy specimens obtained from mature burn scars pre- and postfractional CO2 laser resurfacing show histologic changes that are consistent with the clinical improvement achieved, but further data is needed to understand the mechanisms leading to normal skin regeneration, reported David M. Ozog, M.D., at the 2011 annual meeting of the American Society for Laser Medicine and Surgery.

The surgical removal of the lymph nodes in patients who are found to have positive nodes after undergoing sentinel lymph node biopsy (SLNB) improves survival, compared to patients who have melanoma spread to lymph nodes when the disease is large enough to be felt with a physical examination, according to a surgical oncologist.